Webster Equity Partners to Acquire Lifecore Biomedical

Lifecore Biomedical sale to affiliates of Webster Equity Partners

October 3, 2026

Healthcare Services

Lifecore Biomedical, Inc. (LFCR) is the subject of an inquiry related to its proposed sale to affiliates of Webster Equity Partners. The announcement states that Lifecore shareholders are expected to receive $6.28 in cash per share plus a contingent value right tied to future revenue and EBITDA milestones through 2030.

Repligen Acquires BioLife Solutions for $1.5 Billion

July 23, 2026

Healthcare Services

Repligen has entered into a definitive agreement to acquire BioLife Solutions in a cash-and-stock transaction with an enterprise value of approximately $1.5 billion. The deal is expected to close in the fourth quarter of 2026, subject to BioLife shareholder approval and regulatory clearances.

Equitable Holdings and Corebridge Financial Merge in ~$22B All-Stock Deal

March 25, 2026

Financial Services

Equitable Holdings and Corebridge Financial entered into a definitive all-stock merger valued at approximately $22 billion, creating a scaled retirement, life, wealth and asset management company with more than 12 million customers. The combined company will operate under the Equitable name and is expected to close by year-end 2026 (subject to regulatory approvals and customary closing conditions).

Merit Medical Systems Acquires Biolife Delaware

May 28, 2025

Medical Devices

Merit Medical Systems has acquired Biolife Delaware, a Sarasota, Florida-based maker of StatSeal and WoundSeal hemostatic devices, in a cash transaction valued at approximately $120 million (including assumed liabilities). The deal expands Merit's hemostasis and wound-care product portfolio and is expected to modestly impact 2025 non-GAAP profitability while enhancing Merit's ability to serve a broad set of percutaneous procedure end markets.

Webster Equity Partners and Gurnet Point Capital Acquire Corium's Manufacturing Business and Invest in Corium Neuroscience

October 20, 2022

Pharmaceuticals

Webster Equity Partners and Gurnet Point Capital have acquired Corium's manufacturing business (now Corium Pharma Solutions) in a transaction valuing the CDMO at more than $400 million, while Webster also made a concurrent $100 million equity investment in Corium's neuroscience commercialization business. The deal splits Corium into two independent companies — a CDMO and a neuroscience therapeutics commercialization company — with Gurnet Point and Webster jointly owning the CDMO and holding board representation in both businesses.

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.